JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120046

NBQX disodium salt, AMPA / kainate antagonist

NBQX disodium salt, AMPA / kainate antagonist

5

(1 Review)

|

(74 Publications)

NBQX disodium salt (ab120046) is a water soluble, potent, selective and competitive AMPA/kainate receptor antagonist. Neuroprotective and anticonvulsant in vivo. MW 380.25.

- Available in different sizes to fit your experimental needs
- Cited in over 60 publications

別名を表示する

AMPA 1, AMPA-selective glutamate receptor 1, GLUH1, GRIA1_HUMAN, GluA1, GluR-1, GluR-A, GluR-K1, Glutamate receptor 1, Glutamate receptor ionotropic, Glutamate receptor ionotropic AMPA 1, HBGR1, MGC133252, OTTHUMP00000160643, OTTHUMP00000165781, OTTHUMP00000224241, OTTHUMP00000224242, OTTHUMP00000224243

2 Images
Chemical Structure - NBQX disodium salt, AMPA / kainate antagonist (AB120046)
  • Chemical Structure

Lab

Chemical Structure - NBQX disodium salt, AMPA / kainate antagonist (AB120046)

2D chemical structure image of ab120046, NBQX disodium salt, AMPA / kainate antagonist

Functional Studies - NBQX disodium salt, AMPA / kainate antagonist (AB120046)
  • FuncS

Unknown

Functional Studies - NBQX disodium salt, AMPA / kainate antagonist (AB120046)

ab96379 staining MEK1 (phospho S298) in SK-N-SH cells treated with NBQX disodium salt (ab120046), by ICC/IF. Decrease in MEK1 (phospho S298) expression correlates with increased concentration of NBQX disodium salt, as described in literature.
The cells were incubated at 37°C for 24h in media containing different concentrations of ab120046 (NBQX disodium salt) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab96379 (1/100 dilution) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody.

Key facts

CAS番号

479347-86-9

精製度

>98%

製品の状態

Solid

form

分子量

380.25 Da

分子式

C<sub>1</sub><sub>2</sub>H<sub>6</sub>N<sub>4</sub>Na<sub>2</sub>O<sub>6</sub>S

PubChem

3272523

由来

Synthetic

化学名

6-Nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione, Disodium Salt

生物学的記述

Water soluble, potent, selective and competitive AMPA/kainate receptor antagonist. Neuroprotective and anticonvulsant in vivo.

Canonical smiles

C1=CC2=C3C(=CC(=C2C(=C1)S(=O)(=O)N)[N+](=O)[O-])N=C(C(=N3)[O-])[O-].[Na+].[Na+]

InChi

InChI=1S/C12H8N4O6S.2Na/c13-23(21,22)8-3-1-2-5-9(8)7(16(19)20)4-6-10(5)15-12(18)11(17)14-6;;/h1-4H,(H,14,17)(H,15,18)(H2,13,21,22);;/q;2*+1/p-2

InChiKey

SVJKYIUJRJEABK-UHFFFAOYSA-L

IUPAC名

disodium;6-nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-diolate

製品の詳細

Check out our range of AMPA / kainate antagonist here

出荷温度及び保存条件

出荷温度
Ambient - Can Ship with Ice
短期保存温度
+4°C
長期保存温度
+4°C
保管に関する情報
Store under desiccating conditions|The product can be stored for up to 12 months

This product is supplied in one (or more) pack size which is freeze dried. Therefore the contents may not be readily visible, as they can coat the bottom or walls of the vial. Please refer to our product support page for more details on handling.

|

Need more advice on solubility, usage and handling? Please visit our our product support page for more details.

|

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

|

Refer to SDS for further information.

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Dysfunction in GluR1 and associated AMPA receptors has been implicated in conditions like Alzheimer's disease and epilepsy. Alzheimer's disease exhibits decreased synaptic transmission and plasticity linked to impaired GluR1 function and its interactions with NMDA receptors. In epilepsy abnormal GluR1 activity may contribute to heightened neuronal excitability and seizure propagation. Targeting GluR1 or associated pathways offers potential for therapeutic interventions in these disorders possibly through drugs such as memantine and NBQX which modulate receptor activity.
Pathways

The GluR1-containing AMPA receptors participate significantly in the glutamatergic signaling pathway which is vital for fast excitatory synaptic transmission in the brain. This pathway also involves the NMDA receptors which work together with AMPA receptors to regulate synaptic plasticity and neuronal communication. Additionally the GluR1 interacts within the long-term potentiation (LTP) pathway contributing to the strengthening of synapses an essential mechanism underlying learning and memory.

Biological function summary

The GluR1 subunit is an essential component of the AMPA receptor complex which typically forms as a tetramer. This complex modulates synaptic strength and plasticity processes critical for learning and memory. The activity of AMPA receptors including those containing GluR1 is regulated by several auxiliary proteins and is essential for post-synaptic responses. The GluR1 subunit also interacts with other proteins such as TARPs which modulate its trafficking and channel properties.

Glutamate Receptor 1 (AMPA subtype) also known as GluR1 is a subunit of the AMPA receptor complex which mediates fast synaptic transmission in the central nervous system. It is an ionotropic receptor for glutamate functioning by opening ion channels to allow the flow of Na+ and Ca2+ ions across the cell membrane contributing to excitatory neurotransmission. The GluR1 subunit has a molecular mass of approximately 100 kDa. This receptor is commonly expressed in the brain regions such as the hippocampus and the cerebral cortex playing an important role in synaptic plasticity and memory formation.

製品プロトコール

文献 (74)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:5663 PubMed40595546

2025

Thalamocortical feedback selectively controls pyramidal neuron excitability.

Applications

Unspecified application

Species

Unspecified reactive species

Federico Brandalise,Ronan Chéreau,I-Wen Chen,David van Oorschot,Claudia Morin Raig,Tanika Bawa,Nandkishor Mule,Stéphane Pagès,Foivos Markopoulos,Anthony Holtmaat

eLife 13: PubMed40013677

2025

Characterization of direct Purkinje cell outputs to the brainstem.

Applications

Unspecified application

Species

Unspecified reactive species

Christopher H Chen,Zhiyi Yao,Shuting Wu,Wade G Regehr

eLife 13: PubMed39819796

2025

Realistic mossy fiber input patterns to unipolar brush cells evoke a continuum of temporal responses comprised of components mediated by different glutamate receptors.

Applications

Unspecified application

Species

Unspecified reactive species

Vincent Huson,Wade G Regehr

Science advances 11:eadq6663 PubMed39823338

2025

Control of striatal circuit development by the chromatin regulator .

Applications

Unspecified application

Species

Unspecified reactive species

Kyuhyun Choi,Nathan T Henderson,Emily R Feierman,Sean Louzon,Jamie Galanaugh,Felicia Davatolhagh,Isha Bhandaru,David J Tischfield,Stewart A Anderson,Erica Korb,Marc V Fuccillo

The Journal of neuroscience : the official journal of the Society for Neuroscience 44: PubMed39147589

2024

Heterogeneity in Slow Synaptic Transmission Diversifies Purkinje Cell Timing.

Applications

Unspecified application

Species

Unspecified reactive species

Riya Elizabeth Thomas,Franziska Mudlaff,Kyra Schweers,William Todd Farmer,Aparna Suvrathan

iScience 27:110145 PubMed38952682

2024

Layer specific regulation of critical period timing and maturation of mouse visual cortex by endocannabinoids.

Applications

Unspecified application

Species

Unspecified reactive species

Taisuke Yoneda,Katsuro Kameyama,Takahiro Gotou,Keiko Terata,Masahiro Takagi,Yumiko Yoshimura,Kenji Sakimura,Masanobu Kano,Yoshio Hata

Nature communications 15:5095 PubMed38876987

2024

Scanless two-photon voltage imaging.

Applications

Unspecified application

Species

Unspecified reactive species

Ruth R Sims,Imane Bendifallah,Christiane Grimm,Aysha S Mohamed Lafirdeen,Soledad Domínguez,Chung Yuen Chan,Xiaoyu Lu,Benoît C Forget,François St-Pierre,Eirini Papagiakoumou,Valentina Emiliani

Nature neuroscience 27:484-496 PubMed38233682

2024

The developmental timing of spinal touch processing alterations predicts behavioral changes in genetic mouse models of autism spectrum disorders.

Applications

Unspecified application

Species

Unspecified reactive species

Aniqa Tasnim,Ilayda Alkislar,Richard Hakim,Josef Turecek,Amira Abdelaziz,Lauren L Orefice,David D Ginty

eLife 12: PubMed37490401

2023

Neuropeptide Y-expressing dorsal horn inhibitory interneurons gate spinal pain and itch signalling.

Applications

Unspecified application

Species

Unspecified reactive species

Kieran A Boyle,Erika Polgar,Maria Gutierrez-Mecinas,Allen C Dickie,Andrew H Cooper,Andrew M Bell,Evelline Jumolea,Adrian Casas-Benito,Masahiko Watanabe,David I Hughes,Gregory A Weir,John S Riddell,Andrew J Todd

Cell reports 40:111440 PubMed36170833

2022

Dopamine D2 receptors bidirectionally regulate striatal enkephalin expression: Implications for cocaine reward.

Applications

Unspecified application

Species

Unspecified reactive species

Kathy Z Dai,In Bae Choi,Ryan Levitt,Mariah B Blegen,Alanna R Kaplan,Aya Matsui,J Hoon Shin,Miriam E Bocarsly,Eleanor H Simpson,Christoph Kellendonk,Veronica A Alvarez,Lauren K Dobbs
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com